SRI International Digest #20 - Winter 2006 Subscribe to the SRI International Digest, our quarterly e-newsletter, or view previous issues.
SRI News
Marine Technology R&D Facility in Florida Established SRI has chosen St. Petersburg, Florida as the site for a new marine technology research facility. The new facility, which will be called SRI-St. Petersburg, will accelerate research and development of technologies related to ocean science, the maritime industry and port security. SRI's expansion into Florida is a collaboration with the University of South Florida's College of Marine Science and its Center for Ocean Technology, and is supported by the City of St. Petersburg, Pinellas County and the State of Florida. In a statement, Florida Governor Jeb Bush noted that the new facility will position the state at the forefront of the nation's marine exploration and discovery efforts in ocean science, maritime industry, and port security. In the news: Read a St. Petersburg Times report. SRI Establishes Center for Advanced Drug Research in Virginia In partnership with the Commonwealth of Virginia, Virginia Economic Development Partnership, Shenandoah Valley Partnership, Rockingham County, the City of Harrisonburg and James Madison University, SRI will establish a new facility in Harrisonburg, Virginia. Plans for the facility, which will be called SRI-Shenandoah Valley, include a new Center for Advanced Drug Research (CADRE). The Center will focus on practical applications of the science of proteomics, a core of modern biosciences, to create new diagnostics, therapeutics, and vaccines for infectious disease and biodefense. SRI also plans to add other high-technology programs in areas such as information technology and education at the new site. SRI Provides Mapping and Localization Technology for Microsoft Robotics Studio SRI will deliver a version of its advanced mapping and localization software for Microsoft Robotics Studio, a new Windows®-based environment for academic, hobbyist and commercial developers to easily create robotic applications for a variety of computing platforms. SRI has been a leader in robotic software research and development since the founding of its Artificial Intelligence Center in 1966. Today, SRI continues its leadership in the field with a sophisticated suite of high-level robotic reasoning capabilities that have been deployed on a number of mobile robots.
$56.9 Million Contract for Anti-Infective Drug Development Services to NIH
More information
Link between Smoking Cessation and Sleep Problems Studied
In a new study for the National Institutes of Health, SRI is investigating the effects of smoking cessation and related treatments on sleep. The study, conducted by SRI's Center for Health Sciences, is one of the first collaborations of its kind between scientists studying sleep and those studying nicotine addiction. More information
Safety and Toxicology Studies Begin on New Cancer Drug In an agreement with Taiwan Liposome Company (TLC), a biopharmaceutical company, SRI has begun preclinical safety and toxicology studies of a new cancer drug developed by TLC. In the press: Read a Drug Discovery News article. High-Performance Polymer Technology Licensed to Asahi Kasei Fibers Asahi Kasei Fibers Corporation, a core operating company of the Asahi Kasei Group, has licensed use of SRI's patented aliphatic polyketone polymer technology. Asahi Kasei Fibers intends to use SRI’s polymer technology in the development of high-performance fiber products. The high-performance polymer technology has superior strength and resistance to a wide variety of chemicals, fuels, liquids and organic solvents. The technology was formerly branded as Carilon and originally developed by Shell Oil Company. Changing Lives: A Study of Internet Usage by Low-Income Americans Results are in on a study evaluating Internet usage among low-income Americans participating in a program that increases their access to technology. The report examined the impact of One Economy Technology programs in San Jose, California and Miami, Florida, which brought affordable computers and Internet access into the homes of 200 families. The findings show that people able to access the Internet at home did so at higher rates than other low-income Americans. Program participants reported feeling more capable and less disadvantaged in relation to others. Not only did technology empower them to take action, but their lives were more emotionally enriched. Café Scientifique Has New Home at SRI SRI is the new host for Café Scientifique Silicon Valley. Café Scientifique is part of a growing international trend for "science cafes" that provide community forums to discuss science issues in plain English and outside of a traditional academic context. Café Scientifique’s monthly events are free and open to the public. Café Scientifique Silicon Valley’s next event will be on January 9 from 6:00 to 7:30 p.m. at SRI’s Menlo Park headquarters. Dr. Terry Root of Stanford University will speak on the impact of human-induced climate change on plants and animals. Her work suggests that protecting species on earth is no longer just a habitat protection issue, but also one of limiting climate change. More information
Read about SRI’s world-changing innovations, our history, and view a letter from SRI President and CEO Dr. Curt Carlson here. Watch a KGO-TV news report about our anniversary. SRI’s pioneering Artificial Intelligence Center also recently celebrated its 40th anniversary. SRI Honored as a "Silicon Valley Best Place to Work" The annual award is given by San Jose Magazine and recognizes local companies dedicated to being an employer of choice. SRI was also recognized in 2006 (for the third consecutive year) as a "Best Place to Work" by San Francisco Business Times, East Bay Business Times and Silicon Valley/San Jose Business Journal. SRI Receives Prestigious Award for Outstanding Security Achievement SRI has received the 2006 James S. Cogswell Outstanding Industrial Security Achievement Award from the Defense Security Service (DSS). For more information on SRI's innovations and how we can help you, contact SRI Digest editor Marty Mallonee at marty.mallonee@sri.com. The SRI Digest welcomes your feedback. Please send suggestions or comments to newsletter@sri.com. Start or discontinue a subscription by sending an email to newsletter@sri.com. Read the SRI Digest in Japanese (Spring 2006 edition).
Copyright 2006 SRI International. All rights reserved.
|
||||
SRI has been awarded a $56.9 million contract with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to provide preclinical services for the development of drugs and antibodies for anti-infective therapeutics. SRI will provide five years of support for the development of treatments for avian flu, SARS, West Nile virus, hepatitis, and biodefense pathogens and toxins. 
Smoking remains one of the largest contributing factors to health problems in the U.S., responsible for at least 400,000 deaths per year, and is a leading cause of heart and lung disease. Medications currently used to help quit smoking can have side effects that result in sleep problems, leading to a less effective cessation program. 
In 2006, SRI is celebrating 60 years of world-changing innovations that have brought lasting benefits to the world. At a special anniversary event held on November 6 at the 
About Us 
R&D Divisions Careers Newsroom Contact Us
©2012 SRI International 333 Ravenswood Avenue, Menlo Park, CA 94025-3493
SRI International is an independent, nonprofit corporation. Privacy policy